Meisam Naeimi Kararoudi

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Venues

Blood advances

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lotus Neidemire-Colley, Shrijan Khanal, Kara Marie Braunreiter, Yandi Gao, Rathan Kumar, Katiri Snyder, Margot A Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing Keung Chan, Meisam Naeimi Kararoudi, Hannah K Choe, Ramiro Garzon, Parvathi Ranganathan
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. Blood advances (2024)
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, Yandi Gao, Rathan Kumar, Katiri J Snyder, Margot A Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing Keung Chan, Meisam Naeimi Kararoudi, Hannah K Choe, Ramiro Garzon, Parvathi Ranganathan
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. Blood advances 8 (4) (2024)
Lotus Neidemire-Colley, Shrijan Khanal, Kara Marie Braunreiter, Yandi Gao, Rathan Kumar, Katiri Snyder, Margot A Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing Keung Chan, Meisam Naeimi Kararoudi, Hannah K Choe, Ramiro Garzon, Parvathi Ranganathan
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. Blood advances (2024)
Lotus Neidemire-Colley, Shrijan Khanal, Kara M Braunreiter, Yandi Gao, Rathan Kumar, Katiri J Snyder, Margot A Weber, Simran Surana, Olimjon Toirov, Malith Karunasiri, Molly E Duszynski, Mengna Chi, Punam Malik, Sonu Kalyan, Wing Keung Chan, Meisam Naeimi Kararoudi, Hannah K Choe, Ramiro Garzon, Parvathi Ranganathan
CRISPR/Cas9 deletion of MIR155HG in human T cells reduces incidence and severity of acute GVHD in a xenogeneic model. Blood advances 8 (4) (2024)
Md Faqrul Hasan, Amanda R Campbell, Tayler J Croom-Perez, Jeremiah L Oyer, Thomas A Dieffenthaller, Liza D Robles-Carrillo, Catherine A Cash, Jonathan E Eloriaga, Sanjana Kumar, Brendan W Andersen, Meisam Naeimi Kararoudi, Brian P Tullius, Amanda J Lee, Alicja J Copik
Knockout of the inhibitory receptor TIGIT enhances the antitumor response of ex vivo expanded NK cells and prevents fratricide with therapeutic Fc-active TIGIT antibodies. Journal for immunotherapy of cancer 11 (12) (2023)

Meisam Naeimi Kararoudi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Meisam Naeimi Kararoudi